Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALLO compared with ACHV: revenue, margins and what each company keeps, and the suppliers and customers both name
ALLO
Allogene Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ACHV
Achieve Life Sciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALLO
Allogene Therapeutics, Inc.
vs
ACHV
Achieve Life Sciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ALLO
12
PFE
Pfizer
supplier
NTRA
Natera
supplier
CLLS
Cellectis
supplier
—
Arbor Biotechnologies
unlisted
supplier
8 more · ALLO chain
›
Shared
0
No shared counterparties.
Only ACHV
4
—
Sopharma, AD
unlisted
supplier
—
University of Bristol
unlisted
supplier
—
Adare Pharma Solutions
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Kristen Slaoui
unlisted
supplier
ALLO
Allogene Therapeutics, Inc.
Change
1.13
▲
+3.21%
· post 1.13
· delayed
Mkt cap
$376.6M
Revenue
$5M
Q2 FY26
ACHV
Achieve Life Sciences, Inc.
Change
6.74
▲
+1.96%
· post 6.83
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$680.2M
Revenue
—
vs
Compare
After hours
Nov 3 '26
delayed
ALLO
Allogene Therapeutics, Inc.
vs
ACHV
Achieve Life Sciences, Inc.
1.13
▲
+3.21%
post 1.13
delayed
Price
6.74
▲
+1.96%
post 6.83
delayed
$376.6M
Mkt cap
$680.2M
Q2 FY26
$5M
Revenue
—
Change
Change
ALLO
1.13
▲
+3.21%
vs
ACHV
6.74
▲
+1.96%
After hours
Nov 3 '26
delayed